# LexMS “7 Axes” Benchmark vNext  
## Advanced Stress Set for Cross-Axis Human Biology Reasoning

---

## **AXIS 1: ANATOMY (Structural)**

#### **Level 1 – Basic User Query**
*"I have a mutation in LMNA. Which parts of my body are most likely to be affected and why?"*

#### **Level 2 – Clinical Application**
*"List all UBERON anatomical structures that contain cell types expressing SCN5A above the 75th percentile in GTEx, and identify which of those structures participate in electrical conduction or pacemaker activity."*

#### **Level 3 – Systems Integration**
*"Build a multi-scale anatomy network for ‘pulmonary hypertension’ showing: (a) cellular targets, (b) affected tissues, (c) organ-level remodeling, and (d) systemic cardiovascular consequences. Link each node to MONDO/HPO terms and the genes most strongly implicated."*

#### **Level 4 – Predictive Modeling**
*"Given a loss-of-function mutation in TGFBR2, predict which anatomical structures will show primary vs secondary pathology over time. Use tissue expression, regulatory context, and known phenotypes to produce a ranked anatomical progression map with uncertainty estimates."*

#### **Level 5 – Theoretical Bioengineering**
*"Design a complete artificial ‘respiratory micro-organ’ replacement system that could oxygenate blood without lungs. Identify every anatomical interface (vascular, immune, neural), required cellular microenvironment, and compensatory structural adaptations across the whole body."*

---

## **AXIS 2: GENOMICS (DNA)**

#### **Level 1 – Basic User Query**
*"What does it mean if I have a pathogenic ClinVar variant in MYH7 but it’s very rare in gnomAD?"*

#### **Level 2 – Pharmacogenomics**
*"From a full genome, calculate a personalized drug-risk profile for anticoagulants and statins using CYP variants, transporter genes, and ClinVar drug response annotations. Output a medication-by-dose-adjustment table with evidence strength."*

#### **Level 3 – Population Genetics**
*"Analyze selection pressure and population divergence on SLC6A4 across major ancestral groups using gnomAD frequencies. Identify variants under strongest constraint and infer their likely trait impacts via HPO/MONDO linkage."*

#### **Level 4 – Synthetic Biology**
*"Propose a ‘genomic resilience edit set’ of 50 variants to minimize lifetime risk of cardiovascular disease *without* increasing cancer risk. Use ClinVar, population constraint, regulatory overlap, and pathway side-effects to justify each edit."*

#### **Level 5 – Species Engineering**
*"Design a full-genome engineering plan for human hibernation capacity. Specify the required DNA-level changes, regulatory control elements, tissue-specific expression shifts, and predicted phenotypic outcomes. Include cross-axis justification for every system-level adaptation."*

---

## **AXIS 3: TRANSCRIPTOMICS (RNA)**

#### **Level 1 – Basic User Query**
*"Why might a splice variant be harmful even if the DNA change looks small?"*

#### **Level 2 – Tissue Specificity**
*"For a given variant with high SpliceAI score, list all affected transcripts (GENCODE), quantify predicted splice disruption per transcript, and rank the tissues where the disrupted transcripts dominate expression. Explain the tissue-specific symptom pattern."*

#### **Level 3 – Disease Mechanism**
*"Construct a full transcriptomic cascade for ALS progression: map early mis-splicing events, downstream expression remodeling, affected cell types and tissues, and final HPO phenotypes. Provide causal ordering and evidence sources."*

#### **Level 4 – Therapeutic Targeting**
*"Design a splicing-modulation therapy for a pathogenic exon-skipping event in DMD that restores the dominant muscle transcript while preserving normal isoforms in heart and brain. Provide a cross-tissue targeting strategy and predicted off-target risks."*

#### **Level 5 – Consciousness Engineering**
*"Theoretically design transcriptomic rewiring to increase working memory capacity by 2×. Identify neural circuit targets, gene sets, alternative splicing patterns, metabolic constraints, epigenetic stabilization requirements, and predicted phenome tradeoffs."*

---

## **AXIS 4: PROTEOMICS (Protein)**

#### **Level 1 – Basic User Query**
*"If my variant changes a protein, how can that cause disease?"*

#### **Level 2 – Protein Interactions**
*"Given a missense variant in PIK3CA, map the affected structural region (AlphaFold), list disrupted STRING interactions, and infer which KEGG pathways are most destabilized. Rank pathways by predicted functional loss."*

#### **Level 3 – Structural Prediction**
*"For a rare multi-domain protein variant in LRRK2, predict domain-level conformational changes, altered binding affinity to all known partners, and downstream tissue-specific impacts based on GTEx expression."*

#### **Level 4 – Protein Engineering**
*"Design modified versions of APOE and LDLR that preserve lipid transport but eliminate all known Alzheimer’s and atherosclerosis-associated dysfunction. Justify designs using structural constraints, interaction networks, and phenome risk balancing."*

#### **Level 5 – Biological Immortality**
*"Engineer a theoretically stable protein repair network that prevents age-related proteostasis collapse. Specify required changes to chaperones, ubiquitin-proteasome pathways, mitochondrial maintenance proteins, and DNA repair coupling—while keeping oncogenic risk below baseline."*

---

## **AXIS 5: METABOLOMICS (Biochemistry)**

#### **Level 1 – Basic User Query**
*"How can a gene variant change my metabolism?"*

#### **Level 2 – Metabolic Profiling**
*"Build a personalized metabolism map from variants affecting lipid handling, glucose processing, and detox enzymes. Connect each variant to KEGG pathways, predicted metabolite shifts, and clinical phenotypes (HPO)."*

#### **Level 3 – Systems Metabolism**
*"Model the metabolic transition from pre-diabetes to type 2 diabetes by integrating: (a) variant risk, (b) tissue expression remodeling, (c) pathway flux changes, and (d) phenotypic outcomes. Output a causal pathway graph with feedback loops."*

#### **Level 4 – Metabolic Optimization**
*"Design a metabolic re-engineering strategy to maximize healthy lifespan by reducing oxidative stress while maintaining energy capacity. Specify enzyme targets in glycolysis, TCA, OXPHOS, lipid metabolism, and antioxidant systems, including predicted phenome tradeoffs."*

#### **Level 5 – Photosynthetic Humans**
*"Theoretically engineer partial photosynthetic energy supplementation in human skin. Define compatible metabolic pathways, new organelle requirements, regulatory control, oxygen toxicity mitigation, immune tolerance, and predicted anatomical/phenotypic adaptations."*

---

## **AXIS 6: EPIGENOMICS (Regulation)**

#### **Level 1 – Basic User Query**
*"How can stress or diet change which genes are active without changing DNA?"*

#### **Level 2 – Developmental Programming**
*"Identify ENCODE regulatory elements controlling NR3C1 and FKBP5 in brain and immune tissues, then predict how early-life stress could permanently shift their expression trajectories. Provide a tissue-by-development-stage risk map."*

#### **Level 3 – Epigenetic Inheritance**
*"Map a multi-generation epigenetic transmission model for obesity risk, integrating regulatory elements, gene expression drift, metabolic pathway reinforcement, and phenotypic inheritance. Include paternal vs maternal route differences."*

#### **Level 4 – Epigenetic Reprogramming**
*"Design a rejuvenation strategy that restores youthful chromatin states in muscle and liver while preventing dedifferentiation-driven cancer. Specify regulatory targets, expression endpoints, and safety stop-conditions."*

#### **Level 5 – Memory Engineering**
*"Theoretically design a biological information storage system using programmable methylation patterns in neuronal support cells. Specify encoding rules, retrieval mechanism, stability constraints, and cross-axis impacts on cognition and phenotype."*

---

## **AXIS 7: EXPOSOME / PHENOME (Environment & Traits)**

#### **Level 1 – Basic User Query**
*"Why do people with the same mutation sometimes get very different symptoms?"*

#### **Level 2 – Environmental Genomics**
*"Given variants in detox and inflammatory genes, compute personalized susceptibility to air pollution and endocrine disruptors. Output ranked exposure risks and predicted affected organs/tissues with evidence."*

#### **Level 3 – Phenotype Prediction**
*"Create a full trait-prediction model for early cardiovascular mortality using PRS from ClinVar/gnomAD, regulatory overlap, tissue expression risk, pathway load, and lifestyle exposures. Provide feature weights and uncertainty bounds."*

#### **Level 4 – Adaptive Evolution**
*"Design a long-term public health intervention that could shift population-level resilience to infectious disease across generations. Predict genetic, epigenetic, metabolic, and phenotypic consequences using MONDO/HPO trends."*

#### **Level 5 – Planetary Adaptation**
*"Engineer a complete cross-axis adaptation plan for humans living in high-radiation deep-space colonies for 500 years. Specify genome edits, epigenetic stabilizers, metabolic reconfiguration, anatomical adjustments, and phenotypic safeguards to maintain cognition and reproduction."*

---

## Cross-Axis “Boss Fight” Queries (optional but brutal)

1) **Clinical fusion**  
*"Given: variant list V, phenotypes P (HPO terms), and exposures E. Produce a ranked MONDO disease differential with anatomical impact map (UBERON), causal gene/splice/regulatory justification, and recommended confirmatory tests."*

2) **Mechanism fusion**  
*"Find all variants that (a) are ClinVar pathogenic, (b) have high SpliceAI disruption, (c) affect transcripts dominant in kidney cortex, and (d) map to MONDO diseases with HPO ‘renal cyst’ or ‘proteinuria.’ Output the full evidence table."*

3) **Prediction fusion**  
*"Predict the top 10 future phenotypes for a newborn with a de novo variant in a regulatory element near MECP2. Integrate regulatory effect, transcript impact, tissue developmental expression, known protein networks, metabolic pathways, and MONDO/HPO outcomes."*
